P

Protara Therapeutics

30 employees

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

Basic info

Industry

biotechnology
biotechnology research

Sectors

Biotechnology
Parenteral Nutrition
Choline Deficiency
Orphan Diseases
Rare Diseases
Metabolic Diseases
Corporate Development
Health Care
Short Bowel Syndrome
Therapeutics
Gastrointestinal Diseases
Drug Development
Lymphatic Malformations
Non-Muscle Invasive Bladder Cancer

Date founded

2017

Funding rounds raised

P

Protara Therapeutics raised undisclosed on May 20, 2022

Investors: Red Cedar Ventures

P

Protara Therapeutics raised undisclosed on April 8, 2022

Investors: Red Cedar Ventures

FAQ